Skip to content

CARBOMEDICS ANNULOFLO AR-732Recalls & reported problems

Corcym Srl · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08022057013699), received between Jun 14, 2017 and Jun 14, 2017 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJun 14, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ON (B)(6) 2017, THE MANUFACTURER WAS NOTIFIED BY PATIENT REGISTRATION FORM (PRF) THAT AN ANNULOFLEX MITRAL ANNULOPLASTY RING SZ 32 WAS IMPLANTED AND EXPLANTED ON (B)(6) 2017. DURING THE PROCEDURE THE PHYSICIAN IMPLANTED THE RING, TESTED THE NATIVE MITRAL VALVE AND THEN DECIDED TO REMOVE THE RING. THE PHYSICIAN PERFORMED A SURGICAL REPAIR AND NO RING OR HEART VALVE PROSTHESIS WAS IMPLANTED. THE PROCEDURE WAS EXTENDED BUT THE INCREASE IN X-CLAMP TIME WAS NOT REPORTED TO THE MANUFACTURER. THE RING WAS DISPOSED BY THE HOSPITAL AFTER EXPLANT. NO PATIENT COMPLICATIONS WERE NOTIFIED TO THE MANUFACTURER.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 6640378 ↗

Other RING, ANNULOPLASTY devices

All RING, ANNULOPLASTY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page